{"id":"NCT00542178","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","briefTitle":"Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)","officialTitle":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-10","primaryCompletion":"2009-12","completion":"2009-12","firstPosted":"2007-10-10","resultsPosted":"2013-11-26","lastUpdate":"2018-07-24"},"enrollment":3472,"design":{"allocation":"RANDOMIZED","model":"FACTORIAL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Diabetic Retinopathy"],"interventions":[{"type":"DRUG","name":"Hypoglycemic Agents","otherNames":[]},{"type":"DRUG","name":"Standard glycemia control","otherNames":[]},{"type":"DRUG","name":"Intensive BP treatment","otherNames":[]},{"type":"DRUG","name":"Standard BP control","otherNames":[]},{"type":"DRUG","name":"Fenofibrate","otherNames":[]},{"type":"DRUG","name":"Simvastatin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Intensive glycemia control","type":"EXPERIMENTAL"},{"label":"Standard glycemia control","type":"ACTIVE_COMPARATOR"},{"label":"Intensive BP control","type":"EXPERIMENTAL"},{"label":"Standard BP control","type":"ACTIVE_COMPARATOR"},{"label":"Fibrate","type":"EXPERIMENTAL"},{"label":"Fibrate Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Diabetic retinopathy (DR) is an eye disease that can occur in people with diabetes and can cause poor vision or blindness. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) study is examining the effect of various treatments on cardiovascular disease in people with diabetes. This current study will examine the effects of the ACCORD treatments on the progression of DR in people participating in the ACCORD study.","primaryOutcome":{"measure":"Number of Participants With Progression of Diabetic Retinopathy of at Least 3 Stages on the Early Treatment Diabetic Retinopathy Study (ETDRS) Scale, or Development of Proliferative Diabetic Retinopathy Necessitating Photocoagulation Therapy or Vitrectomy","timeFrame":"Measured at Year 4","effectByArm":[{"arm":"Intensive Glycemia Control","deltaMin":104,"sd":null},{"arm":"Standard Glycemia Control","deltaMin":149,"sd":null},{"arm":"Intensive Blood Pressure Control","deltaMin":67,"sd":null},{"arm":"Standard Blood Pressure Control","deltaMin":54,"sd":null},{"arm":"Fenofibrate + Simvastatin Therapy","deltaMin":52,"sd":null},{"arm":"Placebo + Simvastatin Therapy","deltaMin":80,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.003"},{"comp":"OG002 vs OG003","p":"0.29"},{"comp":"OG004 vs OG005","p":"0.006"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":7,"countries":["United States","Canada"]},"refs":{"pmids":["17599420","20587587","36975019","27289122","25172198","22709833","20212201"],"seeAlso":["http://www.accordtrial.org/"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}